Primary Site >> Liver Cancer

Gene >> TP53

  • 1992
  • 1996
  • 1998
  • 2001
  • 2002
  • 2003
  • 2005
  • 2007
  • 2009
  • 2010
  • 2011
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Low frequency of p53 mutations observed in a diverse collection of primary hepatocellular carcinomas.
PMID: 1329103
Ref: p53 expression and prognosis in gastric carcinoma.
PMID: 1555884
Ref: [Tumor suppressor gene p53. Theoretical principles and their significance for pathology].
PMID: 8710788
Ref: p53 activates the CD95 (APO-1/Fas) gene in response to DNA damage by anticancer drugs.
PMID: 9841917
Ref: Identification of homozygous deletions at chromosome 16q23 in aflatoxin B1 exposed hepatocellular carcinoma.
PMID: 11526514
Ref: Cloning and characterization of a novel 90 kDa 'companion' auto-antigen of p62 overexpressed in cancer.
PMID: 12118381
Ref: Wnt/beta-catenin/tcf signaling: a critical pathway in gastrointestinal tumorigenesis.
PMID: 12481159
Ref: Detection of serum p53 protein in patients with different gastrointestinal cancers.
PMID: 12670524
Ref: Recursive partitioning as an approach to selection of immune markers for tumor diagnosis.
PMID: 14613989
Ref: Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.
PMID: 15901938
Ref: Reduced protein expression of metastasis-related genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer.
PMID: 17504447
Ref: The overexpression of multidrug resistance-associated proteins and gankyrin contribute to arsenic trioxide resistance in liver and gastric cancer cells.
PMID: 19513507
Ref: Enigma negatively regulates p53 through MDM2 and promotes tumor cell survival in mice.
PMID: 21060154
Ref: A triterpenoid from Thalictrum fortunei induces apoptosis in BEL-7402 cells through the P53-induced apoptosis pathway.
PMID: 22086402
Ref: Anticancer potency studies of coordination driven self-assembled arene-Ru-based metalla-bowls.
PMID: 24677392
Ref: Regulatory role of nucleophosmin during the differentiation of human liver cancer cells.
PMID: 24787960
Ref: FV-429 Induced Apoptosis Through ROS-Mediated ERK2 Nuclear Translocation and p53 Activation in Gastric Cancer Cells.
PMID: 25650185
Ref: Epigenetic silencing of BCL6B inactivates p53 signaling and causes human hepatocellular carcinoma cell resist to 5-FU.
PMID: 25909168
Ref: NY-ESO-1 autoantibody as a tumor-specific biomarker for esophageal cancer: screening in 1969 patients with various cancers.
PMID: 25906289
Ref: DNM3 Attenuates Hepatocellular Carcinoma Growth by Activating P53.
PMID: 26784388
Ref: Gain-of-function miRNA signature by mutant p53 associates with poor cancer outcome.
PMID: 26840456
Ref: Raltitrexed Inhibits HepG2 Cell Proliferation via G0/G1 Cell Cycle Arrest.
PMID: 27098147
Ref: Investigating the expression, effect and tumorigenic pathway of PADI2 in tumors.
PMID: 28331341
Ref: Hepatoid Adenocarcinoma of the Stomach: A Challenging Diagnostic and Therapeutic Disease through a Case Report and Review of the Literature.
PMID: 29034239
Ref: Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway.
PMID: 29484412
Ref: The Interaction of Smoking with Gene Polymorphisms on Four Digestive Cancers: A Systematic Review and Meta-Analysis.
PMID: 29721061
Ref: Current insight into a cancer-implicated long noncoding RNA ZFAS1 and correlative functional mechanisms involved.
PMID: 30122315
Ref: Berberine: A potential adjunct for the treatment of gastrointestinal cancers?
PMID: 30125974
Ref: Role of ferroptosis in hepatocellular carcinoma.
PMID: 30167889